Here's why the EMvision share price surged 8% on Wednesday

Investors appear happy about an agreement EMvision has struck with tech company Keysight Technologies.

| More on:
A guy wearing glasses tries to show off his muscles.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • EMvision shares are racing higher today following a company update
  • The company has entered into a strategic agreement with a long-term partner Keysight Technologies
  • In the last 12 months the EMvision share price has fallen more than 38%

The EMvision Medical Devices Ltd (ASX: EMV) share price has emerged from a trading halt on Wednesday morning, and shot 8% into the green.

Prior to their halt, EMVision shares closed at $1.94. Upon returning to trade, they have been sitting in the green amid the release of a company announcement. At the time of writing, EMvision shares are swapping hands at $2.05.

What did EMVision announce?

The company advised it has entered into an original equipment manufacturer (OEM) agreement with Keysight Technologies Inc (NYSE: KEYS).

According to the release, "Keysight is the world leader in radiofrequency (RF) test and measurement technology". Specifically, the company signed its agreement with Keysight's Australian subsidiary.

Under the agreement, EMvision will receive exclusive supply for 'fast sweep' features in the vector network analyser (VNA).

For reference, EMvision says the VNA is a custom solution developed in collaboration with Keysight.

"The VNA is a high performance, lower component count, miniaturised module responsible for accurate signal measurement," states the release.

"The custom VNA represents a strategic investment by Keysight into the electromagnetic imaging sector."

Regarding the announcement, EMvision CEO Dr Ron Weinberger says the collaboration "has been first class".

This Agreement recognises the roles that both parties have played in the development of the bespoke VNA over a period of 3 years. I would like to thank the Keysight team for their concerted work in developing a best-of-breed solution for EMvision and look forward to the commercial phase of our relationship.

Noteworthy is that Keysight is not a medical device manufacturer. However, it does possess "the strongest portfolio of Vector Network Analysers (VNA), which are core to the sensors that are being used inside EMvision's portable brain scanner," says the company.

The agreement builds on a relationship that spawned back in 2019. Then, the pair entered into a strategic collaboration to develop "custom healthcare-focused VNA solutions".

EMvision share price snapshot

In the last 12 months the EMvision share price has fallen more than 38%. Meanwhile, it is 23.5% in the red since trading resumed this year.

Following this announcement, shares have bounced from a low point and are tracking back towards monthly highs.

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended EMvision Medical Devices Limited. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Technology Shares

Soldier in military uniform using laptop for drone controlling.
Technology Shares

This ASX drone tech stock just hit a record high. Here's why investors are piling in

Elsight shares hit a record high as strong momentum, revenue growth, and insider buying attract investor attention.

Read more »

A woman on a green background points a finger at graphic images of molecules, a rocket, light bulbs and scientific symbols as she smiles.
Technology Shares

2 magnificent ASX tech stocks to buy in 2026

Quietly essential, globally relevant, and built for the long term. These are two ASX tech stocks I’m watching closely in…

Read more »

A child dressed in army clothes looks through his binoculars with leaves and branches on his head.
Opinions

Up 735% in a year! The red-hot EOS share price is smashing Droneshield and other defence stocks

Investor interest in defence stocks has boomed.

Read more »

It's raining cash for this man, as he throws money into the air with a big smile on his face.
Technology Shares

Up 700% in 12 months! Why this ASX tech stock just raised $150m

This high-flying stock is raising funds. But why?

Read more »

A montage of planes, ships and trucks, representing ASX transport shares
Technology Shares

Is Wisetech a buy, sell or hold at current levels?

Jarden has run the numbers on the Wisetech share price.

Read more »

a uranium-fuelled mushroom shaped cloud explosion surrounded by a circle of rainbow light with a symbol of an atom to one side of it.
Opinions

What's next for the best-performing ASX 200 stock of 2025?

This ASX stock boomed in 2026.

Read more »

A young man talks tech on his phone while looking at a laptop. A financial graph is superimposed across the image.
Opinions

3 reasons Xero shares are a screaming buy right now

Here's what I expect from the tech stock this year.

Read more »

Piggybank with an army helmet and a drone next to it, symbolising a rising DroneShield share price.
Technology Shares

New all-time high. Why this ASX defence stock is flying again today

EOS shares jump to a record high on defence tailwinds and a broker upgrade.

Read more »